SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014893
Filing Date
2024-11-07
Accepted
2024-11-07 16:47:04
Documents
75
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rzlt-20240930x10q.htm   iXBRL 10-Q 1129072
2 EX-31.1 rzlt-20240930xex31d1.htm EX-31.1 15330
3 EX-32.2 rzlt-20240930xex32d2.htm EX-32.2 7373
  Complete submission text file 0001558370-24-014893.txt   6168631

Data Files

Seq Description Document Type Size
4 EX-101.SCH rzlt-20240930.xsd EX-101.SCH 52459
5 EX-101.CAL rzlt-20240930_cal.xml EX-101.CAL 40470
6 EX-101.DEF rzlt-20240930_def.xml EX-101.DEF 219849
7 EX-101.LAB rzlt-20240930_lab.xml EX-101.LAB 371090
8 EX-101.PRE rzlt-20240930_pre.xml EX-101.PRE 363989
78 EXTRACTED XBRL INSTANCE DOCUMENT rzlt-20240930x10q_htm.xml XML 982136
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39683 | Film No.: 241436715
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)